Why Podcasts Matter for Psilocybin Education
Podcasts have become one of the most accessible formats for serious education about psychedelic science. Unlike academic papers — which are often paywalled, dense, and slow to reach a general audience — and unlike social media, which tends towards anecdote and sensationalism, good psychedelic podcasts occupy a middle ground: long-form, expert-led, nuanced, and free to access. They can carry a full research discussion, a therapist's clinical reflection, or a harm-reduction practitioner's field perspective in a way that written summaries rarely can.
That said, quality varies enormously. Some shows are rigorous and science-forward; others are advocacy vehicles that overstate evidence or romanticise risk. The guidance below helps you identify which type you are listening to, and highlights shows that have demonstrated consistent editorial standards.
Research and Science Podcasts
These shows focus on peer-reviewed evidence, clinical trial results, and the neuroscience of psychedelics. They typically feature researchers, clinicians, and policy experts as guests.
Psychedelics Today
One of the longest-running and most consistently researched podcasts in the field. Hosts Joe Moore and Kyle Buller cover clinical trials, harm-reduction frameworks, integration theory, and policy developments. Guests include researchers from Johns Hopkins, Imperial College London, MAPS, and NYU. Episodes often run 60–90 minutes and go deep into methodology and clinical detail. Suitable for listeners who want primary-source context rather than summaries. Available on Spotify, Apple Podcasts, and the Psychedelics Today website.
The Psychedelic Scientist
A more technical show aimed at listeners with a science background, covering neuropharmacology, receptor pharmacology, and the mechanistic science of how psilocybin affects serotonin receptors — particularly 5-HT2A agonism and its downstream effects on the default mode network. Useful for anyone who wants to understand the neurological basis of clinical findings rather than just the outcomes.
Maps Podcast (MAPS)
Produced by the Multidisciplinary Association for Psychedelic Studies, this podcast covers MAPS-sponsored research, including MDMA-assisted therapy for PTSD and psilocybin therapy programmes. Interviews with researchers and therapists from within the MAPS ecosystem. Note that as a podcast from an advocacy-and-research organisation, it reflects MAPS's perspective and is most useful in combination with independent sources.
The Third Wave Podcast
Hosted by Paul Austin, this show focuses on microdosing and intentional psychedelic use, drawing on both research and practitioner experience. Guests include clinicians, coaches, neuroscientists, and professionals who use psychedelics as part of a structured personal development practice. More accessible in tone than strictly academic shows, with a practical orientation toward protocols and integration.
Therapy and Clinical Podcasts
These podcasts focus on psychedelic-assisted therapy: how it works clinically, what the therapeutic relationship looks like, patient and therapist experiences, and the evolving regulatory landscape.
Psychedelic Medicine Podcast
Hosted by Jefferson Hadley, this show brings in psychiatrists, psychologists, and clinical researchers to discuss psychedelic-assisted therapy from a medical and clinical perspective. Covers FDA and regulatory developments in the US, therapist training requirements, and patient case studies (anonymised). Particularly good for listeners interested in how psychedelic therapy fits into mainstream healthcare systems.
Healing with MAPS
A MAPS-produced series featuring in-depth conversations with clinical trial participants, therapists, and researchers. Episodes walk through the structure of MAPS-protocol therapy sessions, the role of the therapeutic relationship, and what integration looks like in a clinical context. Even though the primary focus is MDMA, the therapeutic principles discussed — non-directive support, trust in the process, integration — apply directly to psilocybin-assisted therapy.
Vital Psychedelic Conversations
Produced by the Vital Institute, this series explores the intersection of psychedelic therapy and somatic, trauma-informed, and IFS (Internal Family Systems) approaches. A useful resource for understanding how integration therapists think about preparing clients and helping them metabolise difficult experiences.
Cultural, Historical, and Policy Podcasts
These shows situate psilocybin within broader cultural, political, and historical contexts — essential for understanding how we arrived at the current regulatory and scientific landscape.
Hamilton's Pharmacopeia (documentary series)
Though primarily a video series (Vice TV), many episodes are available in audio format. Hamilton Morris's deeply reported investigations into the chemistry, history, and culture of psychoactive substances are among the most rigorous in popular media. Episodes on psilocybin cover ethnobotanical history, synthesis chemistry, and the communities that have preserved traditional knowledge. Not a standard podcast format, but valuable for the context it provides.
The Infinite Mindfield
Explores the anthropological and historical dimensions of psychedelic use — Indigenous traditions, the role of altered states in religious and cultural history, and the political circumstances that led to prohibition. A useful counterpoint to purely clinical perspectives, this show reminds listeners that psilocybin has a millennia-long human history outside of the laboratory.
Drug Policy Reform Podcast
Covers drug policy more broadly but regularly features episodes on psychedelic decriminalisation and legalisation efforts — in Oregon, Colorado, the UK, and internationally. Essential listening for anyone interested in the legal trajectory of psilocybin and the harm-reduction case for regulatory reform.
Personal Experience and Integration Podcasts
These shows centre human stories — people who have used psilocybin for therapeutic purposes, personal development, or spiritual exploration, and the integration work that follows.
Insight Psychedelic Journeys
First-person accounts from people who have participated in clinical trials or legal therapeutic programmes. Covers end-of-life anxiety, depression, addiction, and post-traumatic growth. The storytelling is careful to distinguish between what participants attribute to psilocybin and what the clinical data supports — a level of nuance that is rare in this genre.
The Integration Project
Focused specifically on integration — the post-experience process of meaning-making and practical change. Guests include integration therapists, coaches, and people sharing their own post-experience journeys. Particularly useful for harm reduction: integration is the most neglected aspect of psychedelic use, and poor or absent integration is associated with difficult or unresolved experiences.
How to Listen Critically
Not all psychedelic podcasts are equally rigorous. As you explore this genre, apply the following filters:
| Green flag | Red flag |
|---|---|
| Guests cite specific published studies | Claims of "cures" without qualification |
| Host acknowledges limitations and dissenting evidence | Dismissal of risks as overblown or irrelevant |
| Contraindications and safety context included | Blanket encouragement of unsupervised use |
| Guest credentials are verifiable | Unverifiable expert claims ("leading researcher") |
| Legal context provided for the relevant jurisdiction | Legal status ignored or glossed over |
| Integration and preparation discussed | Focus only on the experience itself |
Where to Listen
All of the podcasts listed here are available on major podcast platforms — Spotify, Apple Podcasts, and Google Podcasts — as well as on the producers' own websites. If you are in a location with restricted internet access or limited data, many episodes can be downloaded for offline listening. No subscription or payment is required for any of these shows.
Further Reading
Podcasts are a complement to, not a replacement for, primary sources. After listening, consider following up with:
- The research papers cited in episodes (most hosts provide links in show notes)
- Psilobase's own Research summaries for context and limitations on key clinical findings
- The Safety section before making any practical decisions
- The Glossary for terminology introduced in podcast discussions
Frequently Asked Questions
Are these podcasts suitable for people new to the topic?
Psychedelics Today and The Third Wave are the most accessible entry points for new listeners. The Psychedelic Scientist is better suited to those with a science background. Start with whichever matches your level of prior knowledge.
Do these podcasts promote drug use?
The shows listed here take a harm-reduction approach — they discuss psilocybin in the context of safety, research, and responsibility, not as advocacy for recreational use. They include contraindications, legal context, and integration guidance as standard. This distinguishes them from advocacy-only content.
Can I recommend these podcasts to a friend who is struggling?
For educational context, yes. However, if your friend is in mental health crisis, podcasts are not the right first resource. Direct them to a qualified therapist, their GP, or a crisis line (Samaritans: 116 123; Fireside Project: 623-473-7433) before anything else.
Are there podcasts specifically about microdosing?
The Third Wave Podcast has a dedicated microdosing focus and is a strong starting point. Psychedelics Today also covers microdosing regularly as part of its broader programming.
What is the best podcast for understanding the science?
The Psychedelic Scientist for pharmacology and neuroscience; Psychedelics Today for clinical research and harm-reduction frameworks; MAPS Podcast for trial-specific protocol detail. A mix of all three gives the best coverage of the current evidence base.